|
Gene Vaccines
' p& Y+ b* X) J0 OThalhamer, Josef; Weiss, Richard; Scheiblhofer, Sandra (Eds.)
5 g; F/ s* z3 y9 ~1st Edition., 2012, XI, 330 p. 49 illus., 41 in color.; m+ L2 d: C: ^$ ]# H
) F/ |7 g4 ^+ m$ r# m0 j7 mHardcover, ISBN 978-3-7091-0438-5
_2 I) A; x" B3 a. [Online orders shipping within 2-3 days8 p+ t: o0 t0 L- e& ~6 O
149,95 8 z3 K# e' T$ ^! V
( E, A, |0 }3 G7 W/ `9 S7 e
目录
x1 U0 q6 u) H4 VPreface.- 1 General mechanisms of gene vaccines.- 2 Strategies to Improve DNA Vaccine Potency: HPV-associated Cervical Cancer as a Model System.- 3 Immune-activating mechanisms of replicase-based DNA and RNA vaccines and their role in immune-apoptosis.- 4 Cytokine genes as molecular adjuvants for DNA vaccines.- 5 Pharmaceutical non-viral formulations for gene vaccines.- 6 Rational design of formulated DNA vaccines: the DermaVir approach.- 7 In vivo electroporation.- 8 Electroporation-based Trigrid™ delivery system (TDS) for DNA vaccine administration.- 9 Prime Boost Regimens for Enhancing Immunity: Magnitude, Quality of Mucosal and Systemic Gene Vaccines.- 10 Intranodal genetic immunization.- 11 Immunotherapy of cancer with RNA vaccines.- 12 DNA and RNA vaccines for prophylactic and therapeutic treatment of type I allergy.- 13 Approved veterinary vaccines – paving the way to products for human use.- 14 Current status of regulations for DNA vaccines.- 15 State of the art production of antibiotic resistance-free plasmid DNA.- 16 Industrial Manufacturing of Plasmid-DNA Products for Gene Vaccination and Therapy.8 V; K. S0 C8 x4 D+ U. \$ K/ u
9 n3 K, N. N& n- F4 C/ Z! x下载地址:7 j& s- b$ l: B/ H
# o; T" e+ J3 v$ u
+ ^; ^" T% P+ w9 r$ ?2 T
|
|